| |
Pediatric Academic
Societies' Annual Meeting |

|
| |
|
|
|
|
| |

Sponsored by the: American Pediatric
Society Society for Pediatric
Research Ambulatory Pediatric
Association
Alliance
Organizations
Program
Information
Program
Committee & Contacts
Abstracts
Awards
Registration
& Housing
Exhibits
Sponsorship/Support
Future Meetings
Past Meetings
Meeting
Profiles
Pediatric Related
Links
- Contact
Information
- Mail Address:
- Suite B-7
3400 Research
Forest Drive
- The Woodlands, TX
77381 USA
- Telephone:
281-419-0052
- Facsimile:
281-419-0082
|
|
|
 |
PAS Annual Meeting
May 1 – 4, 2004
San Francisco, California
|
View Full-Text Abstracts |
|
|
|
|
|
|
|
|
Sunday, May 2, 2004
11:45am–1:45pm
2525—Late
Breakers: Infectious Diseases
Poster Session ~ Level 1 Exhibit Hall
| 468 |
Neurologic
Complications Associated with Influenza A in Children
During the 2003–04 Influenza Season in Houston,
Texas (Late-Breaker
Abstract 17)
|
| 469 |
Immunogenicity
of PENTACEL™ When Administered as a Fourth Dose at
15 to 18 Months of Age
(Late-Breaker Abstract 18)
|
| 470 |
A
Study of a New Zealand Epidemic Strain Meningococcal B
Outer Membrane Vesicle Vaccine Targeting P1.7b, 4 Por
A Protein in Healthy 16–24 Month Old Toddlers
(Late-Breaker
Abstract 19)
|
| 471 |
Comparison
of Efficacy and Safety of a Trivalent, Live
Attenuated, Intranasal Influenza Vaccine (CAIV-T) with
Trivalent, Inactivated, Intramuscular Influenza
Vaccine (TIV) in Children and Adolescents Aged 6 to
<18 Years with Asthma
(Late-Breaker Abstract 20)
|
Monday,
May 3, 2004
8:00am–10:00am
3258—Late
Breakers: General Pediatrics
Platform Session ~ Room 2002
Moderator: To Be Announced
| 8:00 |
Temporal
Trends in Pediatric Invasive Pneumococcal Disease in
the Intermountain West (IMW)
(Late
Breaker Abstract 1)
|
| 8:15 |
Clinical
and Epidemiologic Features of Influenza-Associated
Deaths in Children, United States, 2003–2004
Influenza Season
(Late
Breaker Abstract 2)
|
| 8:30 |
A
Randomized Clinical Trial of Estrogen Supplementation
in Adolescent Girls Receiving Depot
Medroxyprogesterone Acetate (DMPA) (Late
Breaker Abstract 3)
|
| 8:45 |
Clinical
Significance of Vesicoureteral Reflux (VUR) and
Urinary Antibiotic Prophylaxis (UAP) After First
Episode of Acute Pyelonephritis (APN)
(Late
Breaker Abstract 4)
|
| 9:00 |
Screening
Jaundiced Newborns Using Transcutaneous Bilirubin (TcB)
Can Reduce the Hospital Re-admission Rate
(Late
Breaker Abstract 5)
|
| 9:15 |
Obese
Patients with Insulin Resistance Experience a
Significant Drop in Plasma Glucose 3–5 Hours After
an Oral Glucose Challenge
(Late
Breaker Abstract 6)
|
| 9:30 |
Comparison
of Efficacy and Safety of a Trivalent Live,
Attenuated, Intranasal Influenza Vaccine (CAIV-T) with
Trivalent Inactivated, Intramuscular Influenza Vaccine
(TIV) in Children Aged 6 to <72 Months with a
History of Respiratory Tract Infections
(Late
Breaker Abstract 7)
|
| 9:45 |
North
American IgA Nephropathy Trial: Evaluation of
Alternate-Day Prednisone (QOD-PRED) or Daily Omega-3
Fatty Acids (OM-3 FA) in Children and Young Adults
with IgA Nephropathy
(Late
Breaker Abstract 8)
|
3:00pm–5:00pm
3737—Late
Breakers: Neonatology
Platform Session ~ Room 3005
Moderators: Neil N. Finer and John P.
Kinsella
| 3:00
|
Indomethacin
for the Prevention of Intraventricular Hemorrhage Is
Effective Only in Boys
(Late
Breaker Abstract 9)
|
| 3:15
|
Immature
Baboons Treated for 28 Days with Early nCPAP Versus
LV-PPV with Delayed Extubation to nCPAP Show
Physiologic and Pathologic Differences
(Late
Breaker Abstract 10)
|
| 3:30
|
High
Frequency nCPAP Provides Adequate Prolonged Support of
the Preterm Lamb
(Late
Breaker Abstract 11)
|
| 3:45
|
Inhaled
Nitric Oxide for Preterm Infants with Severe
Respiratory Failure
(Late
Breaker Abstract 12)
|
| 4:00
|
Short-Term
Mechanical Ventilation Increases Airway Reactivity in
Rat Pups
(Late
Breaker Abstract 13)
|
| 4:15
|
Phase
I/II Double Blind, Placebo Controlled, Dose
Escalation, Safety and Pharmacokinetics Study in Very
Low Birth Weight Neonates of BSYX-A110, an
Anti-Staphylococcal Monoclonal Antibody for the
Prevention of Staphylococcal Bloodstream Infections (Late Breaker Abstract 14) |
| 4:30
|
Conservative
Transfusion Regimens Are Not Associated with Higher
Mortality or Morbidity in ELBW Infants—The Premature
in Need of Transfusion (PINT) Randomized Controlled
Trial
(Late Breaker Abstract 15)
|
| 4:45
|
Actual
Versus Intended Pulse Oxygen Saturation (SpO2) in
Infants <28 Weeks Gestation
(Late Breaker Abstract 16)
|
5:15pm–6:45pm
3979—Late
Breakers: General Pediatrics/Neonatology
Poster Session ~
Level 1 Exhibit Hall
Moderators: Richard Krueger, Jr. and Ashima Madan
| 464 |
Bioequivalence
of Breast Milk from Grandmother Re-lactation HIV
Prevention Trial
(Late
Breaker Abstract 21)
|
| 465 |
Can
High Rates of Influenza Immunization Be Achieved in
Healthy Young Children? Results of a Randomized
Controlled Trial Using Registry-Based Recall
(Late
Breaker Abstract 22)
|
| 466 |
Adolescent
Patients’ Response to Internet Health Information in
Examination Rooms During Wait Times
(Late
Breaker Abstract 23)
|
| 467 |
Multicenter
Trial of Mycophenolate Mofetil (MMF) in Children with
Steroid Dependent (SD) or Frequent Relapsing (FR)
Nephrotic Syndrome (NS). Report of the Southwest
Pediatric Nephrology Study Group
(Late
Breaker Abstract 24)
|
| 468 |
Cerebral
Cortex Thickness in 14-Year-Old Adolescents with Very
Low Birth Weight (VLBW) Measured by an Automated MRI-Based
Method
(Late
Breaker Abstract 25)
|
| 469 |
Changes
in Lung Impedance Following Derecruitment During High
Frequency Ventilation
(Late
Breaker Abstract 26)
|
| 470 |
Assessing
Bone Age in Children with Delayed Development Using
Ultrasound
(Late
Breaker Abstract 27)
|
| 471 |
Two-Year
Neurodevelopmental Outcomes of Premature Infants
Treated with Inhaled Nitric Oxide:
Longitudinal Follow Up of a Prospective,
Randomized Controlled Trial
(Late
Breaker Abstract 28)
|
| |
|
|
|
|
Copyright: All information contained in this
Website is the property of the Pediatric Academic Societies unless
otherwise noted. Duplication of any information contained herein for
reasons other than personal use requires the expressed written permission
of PAS.
For comments or concerns about
the website, please contact mailto:datwood@aps-spr.org.
Last Updated: April 19, 2004 |